XML 40 R20.htm IDEA: XBRL DOCUMENT
v3.20.4

Equity Compensation, Employment Agreements and Other Benefit Plans | 12 Months Ended
--- | ---
Dec. 31, 2020
Compensation Related Costs [Abstract] |
Equity Compensation, Employment Agreements and Other Benefit Plans | Equity Compensation and Other Benefit Plans (a) Equity Compensation Plan In accordance with the terms of the Company’s Equity Plan, which was adopted by the Company’s stockholders on June 10, 2020 (and which amended and restated the Company’s 2010 Equity Compensation Plan), directors, officers and employees of the Company and any of its subsidiaries and other persons expected to provide significant services for the Company and any of its subsidiaries are eligible to receive grants of stock options (“Options”), restricted stock, RSUs, dividend equivalent rights and other stock-based awards under the Equity Plan. Subject to certain exceptions, stock-based awards relating to a maximum of 18.0 million shares of common stock may be granted under the Equity Plan; forfeitures and/or awards that expire unexercised do not count toward this limit. At December 31, 2020, approximately 14.3 million shares of common stock remained available for grant in connection with stock-based awards under the Equity Plan. A participant may generally not receive stock-based awards in excess of 2.0 million shares of common stock in any one year and no award may be granted to any person who, assuming exercise of all Options and payment of all awards held by such person, would own or be deemed to own more than 9.8% of the outstanding shares of the Company’s common stock. Unless previously terminated by the Board, awards may be granted under the Equity Plan until June 10, 2030. Restricted Stock Units Under the terms of the Equity Plan, RSUs are instruments that provide the holder with the right to receive, subject to the satisfaction of conditions set by the Compensation Committee at the time of grant, a payment of a specified value, which may be a share of the Company’s common stock, the fair market value of a share of the Company’s common stock, or such fair market value to the extent in excess of an established base value, on the applicable settlement date. Although the Equity Plan permits the Company to issue RSUs that can settle in cash, all of the Company’s outstanding RSUs as of December 31, 2020 are designated to be settled in shares of the Company’s common stock. All RSUs outstanding at December 31, 2020 may be entitled to receive dividend equivalent payments depending on the terms and conditions of the award either in cash at the time dividends are paid by the Company, or for certain performance-based RSU awards, as a grant of stock at the time such awards are settled. At December 31, 2020 and 2019, the Company had unrecognized compensation expense of $6.8 million and $5.5 million, respectively, related to RSUs. The unrecognized compensation expense at December 31, 2020 is expected to be recognized over a weighted average period of 1.7 years. The following table presents information with respect to the Company’s RSUs during the years ended December 31, 2020, 2019 and 2018:
| For the Year Ended December 31, 2020
| RSUs With Service Condition |  | Weighted Average Grant Date Fair Value |  | RSUs With Market and Service Conditions |  | Weighted Average Grant Date Fair Value |  | Total RSUs |  | Total Weighted Average Grant Date Fair Value
Outstanding at beginning of year: | 1,379,681 |  |  | $ | 7.62 |  |  | 1,301,250 |  |  | $ | 6.78 |  |  | 2,680,931 |  |  | $ | 7.21 |
Granted (1) | 939,046 |  |  | 4.88 |  |  | 763,174 |  |  | 5.50 |  |  | 1,702,220 |  |  | 5.16 |
Settled | (379,272) |  |  | 7.75 |  |  | (441,250) |  |  | 6.48 |  |  | (820,522) |  |  | 7.07 |
Cancelled/forfeited | (110,000) |  |  | 7.59 |  |  | — |  |  | — |  |  | (110,000) |  |  | 7.59 |
Outstanding at end of year | 1,829,455 |  |  | $ | 6.19 |  |  | 1,623,174 |  |  | $ | 6.26 |  |  | 3,452,629 |  |  | $ | 6.22 |
RSUs vested but not settled at end of year | 1,160,416 |  |  | $ | 5.37 |  |  | 409,000 |  |  | $ | 6.91 |  |  | 1,569,416 |  |  | $ | 5.77 |
RSUs unvested at end of year | 669,039 |  |  | $ | 7.61 |  |  | 1,214,174 |  |  | $ | 6.04 |  |  | 1,883,213 |  |  | $ | 6.60 |
| For the Year Ended December 31, 2019
| RSUs With Service Condition |  | Weighted Average Grant Date Fair Value |  | RSUs With Market and Service Conditions |  | Weighted Average Grant Date Fair Value |  | Total RSUs |  | Total Weighted Average Grant Date Fair Value
Outstanding at beginning of year: | 1,206,446 |  |  | $ | 7.57 |  |  | 1,151,250 |  |  | $ | 6.21 |  |  | 2,357,696 |  |  | $ | 6.90 |
Granted (2) | 461,525 |  |  | 7.35 |  |  | 451,000 |  |  | 6.97 |  |  | 912,525 |  |  | 7.16 |
Settled | (269,290) |  |  | 6.93 |  |  | (290,000) |  |  | 4.81 |  |  | (559,290) |  |  | 5.83 |
Cancelled/forfeited | (19,000) |  |  | 7.72 |  |  | (11,000) |  |  | 6.71 |  |  | (30,000) |  |  | 7.35 |
Outstanding at end of year | 1,379,681 |  |  | $ | 7.62 |  |  | 1,301,250 |  |  | $ | 6.78 |  |  | 2,680,931 |  |  | $ | 7.21 |
RSUs vested but not settled at end of year | 809,681 |  |  | $ | 7.70 |  |  | 441,250 |  |  | $ | 6.48 |  |  | 1,250,931 |  |  | $ | 7.27 |
RSUs unvested at end of year | 570,000 |  |  | $ | 7.50 |  |  | 860,000 |  |  | $ | 6.94 |  |  | 1,430,000 |  |  | $ | 7.16 |
| For the Year Ended December 31, 2018
| RSUs With Service Condition |  | Weighted Average Grant Date Fair Value |  | RSUs With Market and Service Conditions |  | Weighted Average Grant Date Fair Value |  | Total RSUs |  | Total Weighted Average Grant Date Fair Value
Outstanding at beginning of year: | 1,025,028 |  |  | $ | 7.67 |  |  | 1,021,250 |  |  | $ | 5.80 |  |  | 2,046,278 |  |  | $ | 6.73 |
Granted (3) | 428,802 |  |  | 7.65 |  |  | 415,000 |  |  | 6.91 |  |  | 843,802 |  |  | 7.29 |
Settled | (237,384) |  |  | 8.17 |  |  | (275,000) |  |  | 5.73 |  |  | (512,384) |  |  | 6.86 |
Cancelled/forfeited | (10,000) |  |  | 7.23 |  |  | (10,000) |  |  | 5.64 |  |  | (20,000) |  |  | 6.44 |
Outstanding at end of year | 1,206,446 |  |  | $ | 7.57 |  |  | 1,151,250 |  |  | $ | 6.21 |  |  | 2,357,696 |  |  | $ | 6.90 |
RSUs vested but not settled at end of year | 708,946 |  |  | $ | 7.47 |  |  | 290,000 |  |  | $ | 4.81 |  |  | 998,946 |  |  | $ | 6.70 |
RSUs unvested at end of year | 497,500 |  |  | $ | 7.71 |  |  | 861,250 |  |  | $ | 6.69 |  |  | 1,358,750 |  |  | $ | 7.06 |
(1)The weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs. In determining the fair value for 1,204,713 of these awards granted in 2020, the Company applied: (i) a weighted average volatility estimate of approximately 14%, which was determined considering historic volatility in the price of the Company’s and its peer group companies’ common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s and peer group companies’ common stock at the grant date; and (ii) a weighted average risk-free rate of 1.36% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards. The weighted average grant date fair value for the remaining 452,585 and 44,922 awards with a service condition only was estimated based on the closing price of the Company’s common stock at the grant date of $2.32 and $2.56, respectively. There are no post vesting conditions on these awards. (2)The weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs. In determining the fair value for 752,500 of these awards granted in 2019, the Company applied: (i) a weighted average volatility estimate of approximately 15%, which was determined considering historic volatility in the price of the Company’s and its peer group companies’ common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s and peer group companies’ common stock at the grant date; and (ii) a weighted average risk-free rate of 2.47% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards. The weighted average grant date fair value for the remaining 160,025 awards with a service condition only was estimated based on the closing price of the Company’s common stock at the grant date of $7.28. There are no post vesting conditions on these awards. (3)The weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs. In determining the fair value for 692,500 of these awards granted in 2018, the Company applied: (i) a weighted average volatility estimate of approximately 17%, which was determined considering historic volatility in the price of the Company’s and its peer group companies’ common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s and peer group companies’ common stock at the grant date; and (ii) a weighted average risk-free rate of 2.36% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards. The weighted average grant date fair value for the remaining 151,302 awards with a service condition only was estimated based on the closing price of the Company’s common stock at the grant date of $7.70. There are no post vesting conditions on these awards. Restricted Stock At December 31, 2020 and 2019, the Company did not have any unvested shares of restricted common stock outstanding. The total fair value of restricted shares vested during the years ended December 31, 2020, 2019 and 2018 was approximately $131,000, $3.2 million and $3.0 million, respectively. The following table presents information with respect to the Company’s restricted stock for the years ended December 31, 2020, 2019 and 2018:
| For the Year Ended December 31,
| 2020 |  | 2019 |  | 2018
| Shares of Restricted Stock |  | Weighted Average Grant Date Fair Value (1) |  | Shares of Restricted Stock |  | Weighted Average Grant Date Fair Value (1) |  | Shares of Restricted Stock |  | Weighted Average Grant Date Fair Value (1)
Outstanding at beginning of year: | — |  |  | $ | — |  |  | — |  |  | $ | — |  |  | — |  |  | $ | — |
Granted | 79,545 |  |  | 1.65 |  |  | 412,185 |  |  | 7.83 |  |  | 450,193 |  |  | 6.74 |
Vested (2) | (79,545) |  |  | 1.65 |  |  | (412,185) |  |  | 7.83 |  |  | (450,193) |  |  | 6.74 |
Cancelled/forfeited | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Outstanding at end of year | — |  |  | $ | — |  |  | — |  |  | $ | — |  |  | — |  |  | $ | — |
(1) The grant date fair value of restricted stock awards is based on the closing market price of the Company’s common stock at the grant date. (2) All restrictions associated with restricted stock are removed on vesting. Dividend Equivalents A dividend equivalent is a right to receive a distribution equal to the dividend distributions that would be paid on a share of the Company’s common stock. Dividend equivalents may be granted as a separate instrument or may be a right associated with the grant of another award (e.g., an RSU) under the Equity Plan, and they are paid in cash or other consideration at such times and in accordance with such rules, as the Compensation Committee of the Board shall determine in its discretion. Payments made on the Company’s outstanding dividend equivalent rights are generally charged to Stockholders’ Equity when common stock dividends are declared to the extent that such equivalents are expected to vest. The Company made dividend equivalent payments associated with RSU awards of approximately $367,000, $1,049,000, and $907,000 during the years ended December 31, 2020, 2019 and 2018, respectively. In addition, no dividend equivalents rights awarded as separate instruments were granted during the years ended December 31, 2020, 2019 and 2018. Expense Recognized for Equity-Based Compensation Instruments The following table presents the Company’s expenses related to its equity-based compensation instruments for the years ended December 31, 2020, 2019 and 2018:
|  | For the Year Ended December 31,
(In Thousands) |  | 2020 |  | 2019 |  | 2018
RSUs |  | $ | 6,592 |  |  | $ | 6,012 |  |  | $ | 4,974 |
Restricted shares of common stock |  | 131 |  |  | 3,227 |  |  | 3,033 |
Total |  | $ | 6,723 |  |  | $ | 9,239 |  |  | $ | 8,007 |
(b) Deferred Compensation Plans The Company administers deferred compensation plans for its senior officers and non-employee directors (collectively, the “Deferred Plans”), pursuant to which participants may elect to defer up to 100% of certain cash compensation. The Deferred Plans are designed to align participants’ interests with those of the Company’s stockholders. Amounts deferred under the Deferred Plans are considered to be converted into “stock units” of the Company. Stock units do not represent stock of the Company, but rather are a liability of the Company that changes in value as would equivalent shares of the Company’s common stock. Deferred compensation liabilities are settled in cash at the termination of the deferral period, based on the value of the stock units at that time. The Deferred Plans are non-qualified plans under the Employee Retirement Income Security Act of 1974 and, as such, are not funded. Prior to the time that the deferred accounts are settled, participants are unsecured creditors of the Company. The Company’s liability for stock units in the Deferred Plans is based on the market price of the Company’s common stock at the measurement date. The following table presents the Company’s expenses related to its Deferred Plans for the years ended December 31, 2020, 2019 and 2018:
|  | For the Year Ended December 31,
(In Thousands) |  | 2020 |  | 2019 |  | 2018
Non-employee directors |  | $ | (911) |  |  | $ | 663 |  |  | $ | (165) |
Total |  | $ | (911) |  |  | $ | 663 |  |  | $ | (165) |
The Company distributed cash of $769,400, $568,900, and $123,700 to the participants of the Deferred Plans during the years ended December 31, 2020 and 2019, respectively. The following table presents the aggregate amount of income deferred by participants of the Deferred Plans through December 31, 2020 and 2019 that had not been distributed and the Company’s associated liability for such deferrals at December 31, 2020 and 2019:
|  | December 31, 2020 |  | December 31, 2019
(In Thousands) |  | Undistributed Income Deferred (1) |  | Liability Under Deferred Plans |  | Undistributed Income Deferred (1) |  | Liability Under Deferred Plans
Non-employee directors |  | $ | 2,197 |  |  | $ | 1,809 |  |  | $ | 2,349 |  |  | $ | 3,071 |
Total |  | $ | 2,197 |  |  | $ | 1,809 |  |  | $ | 2,349 |  |  | $ | 3,071 |
(1)Represents the cumulative amounts that were deferred by participants through December 31, 2020 and 2019, which had not been distributed through such respective date. (c) Savings Plan The Company sponsors a tax-qualified employee savings plan (the “Savings Plan”) in accordance with Section 401(k) of the Code. Subject to certain restrictions, all of the Company’s employees are eligible to make tax-deferred contributions to the Savings Plan subject to limitations under applicable law. Participant’s accounts are self-directed and the Company bears the costs of administering the Savings Plan. The Company matches 100% of the first 3% of eligible compensation deferred by employees and 50% of the next 2%, subject to a maximum as provided by the Code. The Company has elected to operate the Savings Plan under the applicable safe harbor provisions of the Code, whereby among other things, the Company must make contributions for all participating employees and all matches contributed by the Company immediately vest 100%. For the years ended December 31, 2020, 2019 and 2018, the Company recognized expenses for matching contributions of $480,000, $503,500 and $371,000, respectively.

X
- References No definition available. + Details
Name: | us-gaap_CompensationRelatedCostsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for compensation costs, including compensated absences accruals, compensated absences liability, deferred compensation arrangements and income statement compensation items. Deferred compensation arrangements may include a description of an arrangement with an individual employee, which is generally an employment contract between the entity and a selected officer or key employee containing a promise by the employer to pay certain amounts at designated future dates, usually including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period, the number of shares (units) issued during the period under such arrangements, and the carrying amount as of the balance sheet date of the related liability. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 710 -URI http://asc.fasb.org/topic&trid=2127225 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 710 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6409950&loc=d3e20396-108366 + Details
Name: | us-gaap_CompensationRelatedCostsGeneralTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration